시장보고서
상품코드
1299772

레드 바이오테크놀러지 시장 : 제품 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Red Biotechnology Market with COVID-19 Impact Analysis, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 341 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 주요 내용

레드 바이오테크놀러지 시장 규모는 2022년 3,514억 960만 달러로 2023년부터 2030년까지 CAGR 6.2%로 확대

레드 바이오테크놀러지 시장 - 시장 역학:

레드 바이오테크놀러지는 의료 분야의 필수적인 측면으로 등장하여 임상시험, 유전자 치료, 연구, 진단에 두드러진 응용을 하고 있습니다. 또한 생명을 위협하는 질병을 치료하기 위한 다양한 신약의 제조 및 발명, 유전공학 등의 장점도 있습니다. 이러한 요인으로 인해 레드 바이오테크놀러지 시장은 계속 성장하고 있습니다. 그러나 색조 제조 비용과 임상시험 후기 단계의 약물 실패율 증가는 시장 성장을 억제하는 요인입니다. 또한, 발효 기술은 헬스케어 및 생명과학 분야에서 활용되고 있으며, 이는 가까운 미래에 시장 성장을 촉진할 것으로 보입니다.

또한, 시장 개척 기업의 개발 연구 투자 증가, 임상시험의 신약 파이프라인 강화, 제품 제재 강화 등 증가하는 요구 사항에 대응하기 위한 새로운 촉진 장치 설치가 레드 바이오테크놀러지 시장 수익 성장의 주요 요인으로 작용하고 있습니다. COVID-19는 레드 바이오테크 시장에 다소 부정적인 영향을 미치고 있습니다. 의약품 개발 기업은 새로운 경영 문제에 직면하고 있으며, 신약 승인과 함께 임상시험에도 영향을 미칠 것으로 예상됩니다. 약물 연구를 위한 임상시험을 진행하는 시장 관계자들은 환자 등록이 둔화되고 있으며, 병원이 COVID-19 환자를 우선시하기 때문에 일시적으로 시험 시설을 폐쇄해야 하는 상황도 발생하고 있습니다.

레드 바이오테크놀러지 시장 - 세분화 분석:

세계 레드 바이오테크놀러지 시장은 제품 유형, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

단클론항체, 다클론항체, 유전자재조합, 단백질 백신, 세포기반 면역치료제, 유전자치료제, 세포치료제, 조직공학 제품, 줄기세포, 세포배양, 바이러스 벡터, 효소, 키트 및 시약, 동물모델, 분자진단, 기타. 단일클론항체 분야가 가장 큰 시장을 차지할 것으로 예상됩니다. 단클론항체는 그 효과와 안전성으로 인해 COVID-19 완화를 위한 대안으로 떠오르고 있습니다.

이 시장은 용도에 따라 약리유전체학, 바이오의약품 생산, 유전자 치료, 유전자 검사 등 4가지로 분류됩니다. 유전자 치료 분야는 예측 기간 동안 우위를 유지할 것으로 보입니다. 희귀질환의 원인이 되는 다양한 유전성 질환을 치료할 수 있는 치료제의 개선이 이루어지고 있기 때문입니다.

시장은 최종사용자에 따라 연구 기관, CMO & CRO, 바이오 제약 산업 및 기타 세 가지로 분류됩니다. 바이오 제약 산업이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 바이오 제약 산업 분야의 성장의 주요 요인은 연구 개발 노력의 증가가 주요 요인입니다.

레드 바이오테크놀러지 시장 - 경쟁 상황:

기업들은 고객 기반을 확대하기 위해 수익성이 높은 분야에서 생명공학을 구축하는 다른 회사와의 전략적 제휴에 주력하고 있습니다. 또한 시장 참여자들은 제품 확장, M&A, 전략적 제휴, 파트너십, 신제품 출시, 제품 차별화 등 시장 점유율을 확대하기 위한 전략을 추구하고 있습니다. 또한 개인 맞춤형 의료에 대한 수요 증가, 유전자 연구 발전, 생명공학 제품 연구 및 개발에 대한 막대한 투자가 시장 성장을 촉진할 것으로 보입니다. 예를 들어, 2022년 8월 Myovant는 중등도에서 중증의 자궁내막증에 수반되는 통증을 치료하기 위한 relugolix 복합제(Myfembree; Myovant Sciences와 Pfizer)의 FDA 승인을 받았다고 발표했습니다.

연구의 주요 특징

이 보고서는 레드 바이오테크놀러지 시장의 시장 규모, CAGR, 2022년을 기준 연도로 한 추정 및 예측(2023-2030년)을 제공합니다.

이 보고서는 다양한 부문/국가에 걸쳐 잠재적인 성장 기회를 파악하고 레드 바이오테크놀러지 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

이 보고서는 전반적으로 새로운 투자 기회, 기존 기업이 직면한 과제, 레드 바이오테크놀러지 시장에서 지속가능한 성장 요인을 파악합니다.

COVID-19가 레드 바이오테크놀러지 시장 규모, 예측, CAGR, 시장 역학에 미치는 영향은 연구 범위에서 자세히 논의되며, 포스트 코로나 이후 레드 바이오테크놀러지 시장에 대한 자세한 인사이트도 다룹니다.

이 보고서는 사용자에게 레드 바이오테크놀러지 시장에 대한 종합적인 시각을 제공하기 위해 레드 바이오테크놀러지 시장의 경쟁 상황과 주요 혁신가 분석도 포함하고 있습니다.

이 연구는 시장 규모, 성장률, 매력도를 기준으로 모든 산업 부문을 벤치마킹하는 성장 전망 매핑 분석을 포함하고 있습니다.

이 보고서는 주요 시장 진입 기업을 중심으로 상세한 기업 개요를 제공하여 레드 바이오테크놀러지 시장에서 활동하는 기업의 재무 정보 및 전략적 이니셔티브를 이해하는 데 도움이 될 것입니다.

또한, 이 보고서는 세계뿐만 아니라 지역적 차원에서도 주요 시장 참여자들의 중요한 인수합병, 제휴 및 합작투자, 신제품 출시, 연구개발, 지역적 진출 등을 파악할 수 있도록 했습니다.

레드 바이오테크놀러지 세계 시장 보고서는 주로 공급업체, 투자자, 신규 진입자, 유통업체, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.

목차

제1장 레드 바이오테크놀러지 시장 개요

  • 조사 범위

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 레드 바이오테크놀러지 주요 시장 동향

  • 레드 바이오테크놀러지 시장 성장 촉진요인
  • 레드 바이오테크놀러지 시장 성장 억제요인
  • 레드 바이오테크놀러지 시장 기회
  • 레드 바이오테크놀러지 시장 전망 동향

제4장 레드 바이오테크놀러지 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 레드 바이오테크놀러지 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 레드 바이오테크놀러지 시장 상황

  • 레드 바이오테크놀러지 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 레드 바이오테크놀러지 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 단클론항체
    • 다클론항체
    • 재조합
    • 프로테인 백신
    • 세포 기반 면역요법 제품
    • 유전자 치료 제품
    • 세포 치료 제품
    • 조직공학적으로 가공된 제품
    • 줄기세포
    • 세포배양
    • 바이러스 벡터
    • 효소
    • 키트와 시약
    • 동물 모델
    • 분자진단

제8장 기타 레드 바이오테크놀러지 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 약물유전체학
    • 바이오의약품 생산
    • 유전자 치료
    • 유전자 검사

제9장 레드 바이오테크놀러지 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 조사기관
    • CMO와 CRO
    • 바이오의약품 산업

제10장 레드 바이오테크놀러지 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 레드 바이오테크놀러지 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 레드 바이오테크놀러지 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 레드 바이오테크놀러지 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 레드 바이오테크놀러지 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 레드 바이오테크놀러지 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 레드 바이오테크놀러지 산업

  • 경쟁 대시보드
  • 기업 개요
    • Takeda Pharmaceutical Company Ltd.
    • Amgen Inc.
    • Hoffmann-La Roche, Ltd.
    • Merck KGaA
    • Regeneron Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • Biogen Inc.
    • AstraZeneca Plc.
    • Gilead Sciences, Inc.
    • CELGENE CORPORATION
    • Regeneron Pharmaceuticals, Inc.
    • Gilead Sciences, Inc.

제12장 애널리스트의 전방위적 전망

ksm 23.08.17

REPORT HIGHLIGHT

Red Biotechnology Market size was valued at USD 351,409.6 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Red biotechnology is a process that uses in various organisms to improve healthcare and built immunity in disease-fighting. This modern technology is used in the medical field. Additionally, it is not only applicable in the pharmaceutical industry but also the medical industry as it helps to improve lifestyle quality and reduce human suffering. Moreover, it has been utilized in several fields such as diagnostics, research, gene therapy, and clinical trials. The major advantages of red biotechnology include product development and genetic engineering belonging to new medicines for life-threatening diseases treatment.

Red Biotechnology Market - Market Dynamics:

Red biotechnology come up as an essential aspect of the medical field and has noticeable applications in clinical trials, gene therapy, research, and diagnostics. Additionally, it offers other advantages such as the manufacturing and invention of different novel drugs to treat life-threatening diseases and genetic engineering. Owing to such factors flourish the red biotechnology market growth. However, hue manufacturing charges and an increase in the failure rate of drugs in the clinical trials' later stages are such factors that may restrain the market growth. Moreover, fermentation technology is utilized in the healthcare sector and life science, which will drive market growth in the near future.

Furthermore, rising investment in development & research by market players and the emplacement of new-fangled facilitates for addressing augmented requirements, in clinical trials robust pipeline of new drugs, and escalating product sanctions are major drivers in the growth of red biotechnology market revenue. The pandemic COVID-19 has had a slightly negative impact on the red biotechnology market. Drug developers are facing new operational issues and anticipate some influence on clinical trials along with the new drug approvals. Market players that are running clinical trials for the drug investigation are experiencing a slowdown in patient enrollment and they have been forced to close trial sites temporarily, as hospitals prioritize the patient of COVID-19.

Red Biotechnology Market - Segmentation Analysis:

The global red biotechnology market is segmented on the basis of product type, application, end-user, and region.

The market is divided into fifteen categories based on product type: monoclonal antibodies, polyclonal antibodies, recombinant, proteins vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, stem cells, cell culture, viral vectors, enzymes, kits and reagents, animal models, molecular diagnostics, and others. The monoclonal antibodies sector is expected to dominate the largest market. The monoclonal antibodies are alternatives for COVID-19 mitigation due to effectiveness and safety.

The market is divided into four categories based on application: pharmacogenomics, biopharmaceutical production, gene therapy, and genetic testing. The gene therapy sector is likely to maintain its dominance during the forecast period. For the betterment of therapeutics to treat various genetic disorders responsible for rare sicknesses.

The market is divided into three categories based on end-user: research institutes, CMOs & CROs, biopharmaceutical industries, and others. The biopharmaceutical industry sector is expected to hold the largest market share. Rising R&D efforts are a major factor for the biopharmaceutical industries segment growth.

Red Biotechnology Market-Competitive Landscape:

Companies are focusing on strategic partnerships with other companies of biotechnology establish in profitable areas to grow their customer base. Additionally, market players are pursuing strategies to increase their market share including product expansion, mergers & acquisitions, strategic collaborations, and partnerships, launching new products, and product differentiation. Moreover, rising demand for personalized medicine, increase advances in genetic research, and huge investment in R&D of biotechnology products will propel the market growth. For instance, in August 2022, Myovant announced, FDA-approved relugolix combination tablets (Myfembree; Myovant Sciences and Pfizer) to treat moderate-to-severe endometriosis-associated pain.

Key features of the study:

This proposed research study on red biotechnology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for red biotechnology market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the red biotechnology market.

Impact of COVID-19 on red biotechnology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on red biotechnology market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the red biotechnology market, we have also included competitive landscape and key innovator analysis for the red biotechnology market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the red biotechnology market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global red biotechnology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RED BIOTECHNOLOGY MARKET KEY PLAYERS

  • Takeda Pharmaceutical Company Ltd.
  • Amgen Inc.
  • Hoffmann-La Roche, Ltd.
  • Merck KGaA
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Biogen Inc.
  • AstraZeneca Plc.
  • Gilead Sciences, Inc.
  • CELGENE CORPORATION
  • Regeneron Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.

GLOBAL RED BIOTECHNOLOGY MARKET, BY PRODUCT TYPE

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant
  • Proteins Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Stem Cells
  • Cell Culture
  • Viral Vector
  • Enzymes
  • Kits and Reagents
  • Animal models
  • Molecular diagnostics
  • Others

GLOBAL RED BIOTECHNOLOGY MARKET, BY APPLICATION

  • Pharmacogenomics
  • Biopharmaceutical Production
  • Gene Therapy
  • Genetic Testing

GLOBAL RED BIOTECHNOLOGY MARKET, BY END-USER

  • Research Institutes
  • CMOs & CROs
  • Biopharmaceutical Industries
  • Others

GLOBAL RED BIOTECHNOLOGY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Red Biotechnology Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Red Biotechnology Market Snippet by Product Type
    • 2.1.2. Red Biotechnology Market Snippet by Application
    • 2.1.3. Red Biotechnology Market Snippet by End-User
    • 2.1.4. Red Biotechnology Market Snippet by Country
    • 2.1.5. Red Biotechnology Market Snippet by Region
  • 2.2. Competitive Insights

3. Red Biotechnology Key Market Trends

  • 3.1. Red Biotechnology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Red Biotechnology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Red Biotechnology Market Opportunities
  • 3.4. Red Biotechnology Market Future Trends

4. Red Biotechnology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Red Biotechnology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Red Biotechnology Market Landscape

  • 6.1. Red Biotechnology Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Red Biotechnology Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Polyclonal Antibodies
    • 7.1.4. Recombinant
    • 7.1.5. Proteins Vaccines
    • 7.1.6. Cell-Based Immunotherapy Products
    • 7.1.7. Gene Therapy Products
    • 7.1.8. Cell Therapy Products
    • 7.1.9. Tissue-Engineered Products
    • 7.1.10. Stem Cells
    • 7.1.11. Cell Culture
    • 7.1.12. Viral Vector
    • 7.1.13. Enzymes
    • 7.1.14. Kits and Reagents
    • 7.1.15. Animal models
    • 7.1.16. Molecular diagnostics

8. OthersRed Biotechnology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Pharmacogenomics
    • 8.1.3. Biopharmaceutical Production
    • 8.1.4. Gene Therapy
    • 8.1.5. Genetic Testing

9. Red Biotechnology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022&2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. CMOs & CROs
    • 9.1.4. Biopharmaceutical Industries

10. Others Red Biotechnology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Red Biotechnology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Red Biotechnology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Red Biotechnology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Red Biotechnology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Red Biotechnology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Red Biotechnology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Takeda Pharmaceutical Company Ltd.
    • 11.2.2. Amgen Inc.
    • 11.2.3. Hoffmann-La Roche, Ltd.
    • 11.2.4. Merck KGaA
    • 11.2.5. Regeneron Pharmaceuticals, Inc.
    • 11.2.6. Pfizer, Inc.
    • 11.2.7. Biogen Inc.
    • 11.2.8. AstraZeneca Plc.
    • 11.2.9. Gilead Sciences, Inc.
    • 11.2.10. CELGENE CORPORATION
    • 11.2.11. Regeneron Pharmaceuticals, Inc.
    • 11.2.12. Gilead Sciences, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제